Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010
Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Collagen type III content in large airways and distal lung of fatal asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Decreased expression of TGFβ1 type II receptor in bronchial glands of smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004
Type III interferon-λ mRNA expression in sputum of adult and school-aged asthmatics Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
Overexpression of α1β1 integrin (collagen IV receptor) on eosinophils of asthmatic subjects Source: Annual Congress 2003 - Activation, migration and death of immune cells Year: 2003
Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Expression of type 1 and type 2 cytokines in central airways of smokers with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
The influence of roflumilast on the IV-type collagen level in patients with III stage COPD Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012
Changes in lymphocytes functional activity and type I/type II cytokines release in blood of allergic rhinitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 267s Year: 2007
Changes in bronchial mucous membrane depending on the stage of COPD (I, II) Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021
Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008
Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Collagen degradation profile in serum of patients with COPD or IPF Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012
Effects of type I, II and III interferons on endothelin-1 release by human pulmonary artery smooth muscle cells Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011
Proliferation of alveolar type II pneumocytes is stimulated by Jagged-1 in vitro Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012
Type II pneumocyte transplantation in ARDS Source: International Congress 2016 – Cell therapy for ARDS and sepsis Year: 2016